MedPath

Circulating MrgD in Pulmonary Hypertension

Recruiting
Conditions
Pulmonary Hypertension
Registration Number
NCT06365372
Lead Sponsor
Qilu Hospital of Shandong University
Brief Summary

The aim of the study is to observe the change of the circulating MrgD level in patients with pulmonary hypertension compared with subjects without pulmonary hypertension.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Circulating MrgD levelFrom 2022 to 2024
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Qilu Hospital of Shandong University

🇨🇳

Jinan, Shandong, China

Qilu Hospital of Shandong University
🇨🇳Jinan, Shandong, China
Panpan Hao, MD, PHD
Contact
panda.how@126.com
Hongyu Zhong, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.